Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
23.66
-1.39 (-5.55%)
Jun 5, 2026, 1:49 PM EDT - Market open
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $1.95 billion as of June 5, 2026. Its market cap has increased by 86.02% in one year.
Market Cap
1.95B
Enterprise Value
1.33B
1-Year Change
86.02%
Ranking
Category
Stock Price
$23.66
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $1.95B, an increase of 212.35%. That is a compound annual growth rate of 41.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 2.07B | -28.04% |
| Dec 31, 2025 | 2.87B | 368.78% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
| Feb 10, 2023 | 624.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharvaris | 2.20B |
| Enliven Therapeutics | 2.16B |
| Kodiak Sciences | 2.13B |
| Aurinia Pharmaceuticals | 2.11B |
| Intellia Therapeutics | 2.06B |
| Recursion Pharmaceuticals | 2.02B |
| Nektar Therapeutics | 2.00B |
| Trevi Therapeutics | 1.98B |